US Tech 100

18,516.00

-0.10%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Pozen, Inc. (MM) (POZN)
Pozen, Inc. (MM) (POZN) News

POZN

Pozen, Inc. (MM) (POZN)

Pozen, Inc. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:POZN

Date	Time	Source	Headline	Symbol	Company
03/14/2016	2:08PM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:POZN	Pozen, Inc. (MM)
03/14/2016	12:23PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:POZN	Pozen, Inc. (MM)
03/14/2016	12:21PM	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:POZN	Pozen, Inc. (MM)
10/19/2009	8:01AM	PR Newswire (US)	Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers	NASDAQ:POZN
10/16/2009	7:45AM	Dow Jones News	AstraZeneca Submits EU Marketing Application For Vimovo	NASDAQ:POZN	Pozen Inc.
08/31/2009	7:39AM	Dow Jones News	Pozen Earns $10 Million From AstraZeneca As FDA Accepts Drug Application	NASDAQ:POZN	Pozen Inc.
06/30/2009	7:57AM	Dow Jones News	AstraZeneca Partner Pozen Submits PN400 New Drug Application	NASDAQ:POZN	Pozen Inc.
06/30/2009	7:57AM	Dow Jones News	AstraZeneca Partner Pozen Submits PN400 New Drug Application	NASDAQ:POZN	Pozen Inc.
06/08/2007	12:00PM	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks	NASDAQ:POZN
05/02/2007	2:12PM	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks	NASDAQ:POZN
05/02/2007	2:09PM	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms	NASDAQ:POZN
05/03/2006	4:21PM	PR Newswire (US)	American Stock Exchange to Trade Options on Six Securities	NASDAQ:POZN